Matthew Majewski

Vice President

Mr. Matthew Majewski has a track record of providing life science clients with analytically based solutions to their strategic issues.

He has led a wide range of corporate and asset-specific strategy engagements, many of which have focused on pricing and market access. Mr. Majewski has deep experience in the specialty disease space and has provided insights to many clients with rare disease, oncology, and cell & gene therapy assets across the retail, specialty, and hospital channels. Prior to joining CRA, Mr. Majewski was a consultant at a biopharmaceutical organization where he developed and managed market strategies for pre-launch products and designed and managed market organizations.

Selected Engagements

  • 01
    Creating a pricing and contracting strategy for a novel bispecific antibody within the oncology therapeutic area
    Client Issue A leading pharmaceutical company sought support in developing a launch pricing and access strategy for their new bispecific antibody (BsAb)...
    View engagement
  • 02
    Developing a pricing and contracting strategy for a novel dry eye treatment
    Client Issue A leading eye health company sought to develop a US launch pricing and contracting strategy for its novel product to treat dry eye. CRA...
    View engagement